CME
Mechanisms in Myeloma and Related Diseases –
Accreditation Information
Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Imedex, LLC designates the following activities for
AMA PRA Category 1 Credits™,
to a maximum of:
Participants who are eligible to claim AMA PRA Category 1 Credits™ must
complete the self-assessment questions and module evaluation after reviewing the content
of each Learning Module.
Hours Calculated:
A CME Review of each Learning Module was conducted to determine the credit designation for each activity. The estimated time to complete each and the credits assigned are as follows:
| | Estimated Completion Time | Credit Awarded | Release Date | Expiration Date |
|
The Modern Diagnostic Work-Up of Multiple Myeloma and Related Disorders
|
75 minutes
|
1.25
|
12/31/08
|
12/31/09
|
|
Myeloma Bone Disease: Pathogenesis, Diagnosis, and Treatment
|
60 minutes
|
1.00
|
12/31/08
|
12/31/09
|
|
Management of Multiple Myeloma: Risk Factors and Treatment Strategies
|
180 minutes
|
3.00
|
04/09/09
|
04/09/10
|
|
Novel Anticancer Agents and Their Clinical Implications
|
60 minutes
|
1.00
|
12/31/08
|
12/31/09
|
|
Amyloidosis, POEMS, and Castleman Disease
|
75 minutes
|
1.25
|
04/09/09
|
04/09/10
|
|
Waldenström’s Macroglobulinemia
|
40 minutes
|
0.75
|
12/31/08
|
12/31/09
|
| | |
8.25
| | |